PD-1 Inhibitor Therapy in Adult T-Cell Leukemia-Lymphoma
N Engl J Med
.
2018 Aug 16;379(7):696-697.
doi: 10.1056/NEJMc1807852.
Authors
Lee Ratner
1
;
the Authors
Affiliation
1
Washington University School of Medicine, St. Louis, MO
[email protected]
PMID:
30110590
PMCID:
PMC9191750
DOI:
10.1056/NEJMc1807852
No abstract available
Publication types
Letter
Comment
MeSH terms
Adult
B7-H1 Antigen
Humans
Leukemia-Lymphoma, Adult T-Cell*
Programmed Cell Death 1 Receptor*
Substances
B7-H1 Antigen
Programmed Cell Death 1 Receptor
Grants and funding
R21 CA234640/CA/NCI NIH HHS/United States